MIMS online
@mimsonline.bsky.social
Propranolol 80mg and 160mg modified-release capsules will be subject to supply disruption until 2026.
Read more on MIMS
Read more on MIMS
Shortage of propranolol modified-release capsules
Propranolol 80mg and 160mg modified-release capsules will be subject to supply disruption until 2026.
buff.ly
November 12, 2025 at 10:00 AM
Propranolol 80mg and 160mg modified-release capsules will be subject to supply disruption until 2026.
Read more on MIMS
Read more on MIMS
The MHRA has approved low-dose atropine eye drops to slow the progression of myopia in children.
Read more on #MIMSPharma
Read more on #MIMSPharma
MHRA approves first treatment for slowing progression of childhood myopia
The MHRA has approved low-dose atropine eye drops to slow the progression of myopia in children.
buff.ly
November 10, 2025 at 2:02 PM
The MHRA has approved low-dose atropine eye drops to slow the progression of myopia in children.
Read more on #MIMSPharma
Read more on #MIMSPharma
Patients with menopause, especially those from minority ethnic groups, should have the right to request to see the same GP for menopause follow-ups and the option to see a female GP, according to a new report from the APPG on menopause. Find out more on MIMS
Consider longer appointments for minority groups to tackle menopause care disparity, GPs urged
Patients with menopause, especially those from minority ethnic groups, should be given the right to request to see the same GP for return visits about menopause, if possible, as well as the right to…
buff.ly
November 8, 2025 at 2:42 PM
Patients with menopause, especially those from minority ethnic groups, should have the right to request to see the same GP for menopause follow-ups and the option to see a female GP, according to a new report from the APPG on menopause. Find out more on MIMS
This week's news in brief.
▶️ Desogestrel-based contraceptives linked to higher risk of breast cancer than other contraceptives
Read more on MIMS
buff.ly/fHXlzLL
▶️ Desogestrel-based contraceptives linked to higher risk of breast cancer than other contraceptives
Read more on MIMS
buff.ly/fHXlzLL
November 7, 2025 at 2:00 PM
This week's news in brief.
▶️ Desogestrel-based contraceptives linked to higher risk of breast cancer than other contraceptives
Read more on MIMS
buff.ly/fHXlzLL
▶️ Desogestrel-based contraceptives linked to higher risk of breast cancer than other contraceptives
Read more on MIMS
buff.ly/fHXlzLL
Influenza is now circulating in the community with earlier than usual onset of activity, and with an A(H3N2) drifted strain (K, also known as J.2.4.1) predominating, the UKHSA and DHSC have warned
Read more on MIMS
Read more on MIMS
Early start to flu season prompts warning for healthcare professionals
Influenza is circulating in the community earlier than usual, and all eligible groups should be encouraged to get vaccinated as soon as possible, the UK Health Security Agency and DHSC have warned.
buff.ly
November 7, 2025 at 10:00 AM
Influenza is now circulating in the community with earlier than usual onset of activity, and with an A(H3N2) drifted strain (K, also known as J.2.4.1) predominating, the UKHSA and DHSC have warned
Read more on MIMS
Read more on MIMS
Delgocitinib (Anzupgo) has been recommended by NICE as a new treatment option for adults with moderate to severe chronic hand eczema.
Read more on MIMS
Read more on MIMS
New hand eczema treatment recommended for NHS prescribing
A new topical treatment for chronic hand eczema has been recommended by NICE.
buff.ly
November 6, 2025 at 2:03 PM
Delgocitinib (Anzupgo) has been recommended by NICE as a new treatment option for adults with moderate to severe chronic hand eczema.
Read more on MIMS
Read more on MIMS
This week's #drugshortages
▶️ Adartrel 2mg tablets (ropinirole)
▶️ Co-careldopa 25mg/100mg tablets: Somex Pharma
▶️ Cyanokit (hydroxocobalamin)
For more information, see the MIMS Drug Shortages dashboard
buff.ly/udsmNIc
▶️ Adartrel 2mg tablets (ropinirole)
▶️ Co-careldopa 25mg/100mg tablets: Somex Pharma
▶️ Cyanokit (hydroxocobalamin)
For more information, see the MIMS Drug Shortages dashboard
buff.ly/udsmNIc
November 5, 2025 at 2:01 PM
This week's #drugshortages
▶️ Adartrel 2mg tablets (ropinirole)
▶️ Co-careldopa 25mg/100mg tablets: Somex Pharma
▶️ Cyanokit (hydroxocobalamin)
For more information, see the MIMS Drug Shortages dashboard
buff.ly/udsmNIc
▶️ Adartrel 2mg tablets (ropinirole)
▶️ Co-careldopa 25mg/100mg tablets: Somex Pharma
▶️ Cyanokit (hydroxocobalamin)
For more information, see the MIMS Drug Shortages dashboard
buff.ly/udsmNIc
Estradot Conti, a new combined transdermal hormone replacement therapy (HRT) patch, has been launched for NHS prescribing.
Find out more on MIMS
Find out more on MIMS
New combined HRT patch launched
Estradot Conti, a new combined transdermal hormone replacement therapy (HRT) patch, is now available.
buff.ly
November 5, 2025 at 10:30 AM
Estradot Conti, a new combined transdermal hormone replacement therapy (HRT) patch, has been launched for NHS prescribing.
Find out more on MIMS
Find out more on MIMS
As the Pharmacy Contraception Service expands to include #EmergencyContraception, pharmacists can find a handy comparison table on MIMS #AskYourPharmacist
buff.ly/hioAGc8
buff.ly/hioAGc8
November 4, 2025 at 10:01 AM
As the Pharmacy Contraception Service expands to include #EmergencyContraception, pharmacists can find a handy comparison table on MIMS #AskYourPharmacist
buff.ly/hioAGc8
buff.ly/hioAGc8
Catch up on market insight updates for pharma professionals with our quick monthly round-up of key developments affecting primary care prescribing.
Read more on MIMS Pharma
buff.ly/gq4jXKj
Read more on MIMS Pharma
buff.ly/gq4jXKj
buff.ly
November 3, 2025 at 2:00 PM
Catch up on market insight updates for pharma professionals with our quick monthly round-up of key developments affecting primary care prescribing.
Read more on MIMS Pharma
buff.ly/gq4jXKj
Read more on MIMS Pharma
buff.ly/gq4jXKj
The government has sourced additional supplies of pancreatic enzyme replacement therapy, it has confirmed.
Read more on MIMS
Read more on MIMS
Additional pancreatin supplies secured, says government
The government has sourced additional supplies of pancreatic enzyme replacement therapy, it has confirmed.
buff.ly
November 3, 2025 at 12:00 PM
The government has sourced additional supplies of pancreatic enzyme replacement therapy, it has confirmed.
Read more on MIMS
Read more on MIMS
Tirzepatide is associated with a lower risk of major adverse cardiovascular events in obese adults with type II diabetes and metabolic liver disease, according to a cohort study.
Read more on MIMS
buff.ly/wFPWJLf
Read more on MIMS
buff.ly/wFPWJLf
Tirzepatide linked with lower risk of MACE than semaglutide in people with liver disease
Tirzepatide is associated with a lower risk of major adverse cardiovascular events in obese adults with type II diabetes and metabolic liver disease, according to a cohort study.
buff.ly
November 3, 2025 at 10:00 AM
Tirzepatide is associated with a lower risk of major adverse cardiovascular events in obese adults with type II diabetes and metabolic liver disease, according to a cohort study.
Read more on MIMS
buff.ly/wFPWJLf
Read more on MIMS
buff.ly/wFPWJLf
This week's news in brief:
▶️ Tool to predict cardiovascular drug interactions being developed by MHRA using AI
Read more on MIMS
buff.ly/fHXlzLL
▶️ Tool to predict cardiovascular drug interactions being developed by MHRA using AI
Read more on MIMS
buff.ly/fHXlzLL
October 31, 2025 at 2:00 PM
This week's news in brief:
▶️ Tool to predict cardiovascular drug interactions being developed by MHRA using AI
Read more on MIMS
buff.ly/fHXlzLL
▶️ Tool to predict cardiovascular drug interactions being developed by MHRA using AI
Read more on MIMS
buff.ly/fHXlzLL
Use of over-the-counter nasal sprays cut days of illness in adults with a respiratory tract infection, according to a randomised controlled trial.
Read more on MIMS
Read more on MIMS
OTC nasal sprays shorten respiratory infections, trial finds
Use of over-the-counter nasal sprays cut days of illness in adults with a respiratory tract infection, according to a randomised controlled trial.
buff.ly
October 30, 2025 at 6:00 PM
Use of over-the-counter nasal sprays cut days of illness in adults with a respiratory tract infection, according to a randomised controlled trial.
Read more on MIMS
Read more on MIMS
Join MIMS Learning Live North on Wednesday 26 November for:
✅ 6 CPD hours
✅ Lunch and refreshments
✅ Clinical updates you can trust
✅ Network with peers
Hear from Pat Anderson who has put together the programme. And book your place now! mimslearninglive.com/north
✅ 6 CPD hours
✅ Lunch and refreshments
✅ Clinical updates you can trust
✅ Network with peers
Hear from Pat Anderson who has put together the programme. And book your place now! mimslearninglive.com/north
October 30, 2025 at 9:57 AM
Join MIMS Learning Live North on Wednesday 26 November for:
✅ 6 CPD hours
✅ Lunch and refreshments
✅ Clinical updates you can trust
✅ Network with peers
Hear from Pat Anderson who has put together the programme. And book your place now! mimslearninglive.com/north
✅ 6 CPD hours
✅ Lunch and refreshments
✅ Clinical updates you can trust
✅ Network with peers
Hear from Pat Anderson who has put together the programme. And book your place now! mimslearninglive.com/north
This week's #drugshortages include:
▶️ Versatis medicated plasters
▶️ Dalivit multivitamin drops
▶️ Co-careldopa 100mg/25mg tablets
For more information, see the MIMS Drugs Shortages Tracker: buff.ly/udsmNIc
▶️ Versatis medicated plasters
▶️ Dalivit multivitamin drops
▶️ Co-careldopa 100mg/25mg tablets
For more information, see the MIMS Drugs Shortages Tracker: buff.ly/udsmNIc
October 29, 2025 at 2:14 PM
This week's #drugshortages include:
▶️ Versatis medicated plasters
▶️ Dalivit multivitamin drops
▶️ Co-careldopa 100mg/25mg tablets
For more information, see the MIMS Drugs Shortages Tracker: buff.ly/udsmNIc
▶️ Versatis medicated plasters
▶️ Dalivit multivitamin drops
▶️ Co-careldopa 100mg/25mg tablets
For more information, see the MIMS Drugs Shortages Tracker: buff.ly/udsmNIc
The number of patients prescribed HRT in England increased by 6% in 2024/25 compared with the previous financial year, according to NHSBSA statistics.
Find out more on MIMS Pharma
Find out more on MIMS Pharma
Oestrogel dominates HRT market as number of patients prescribed HRT increases by 6% in 2024/25
The number of patients prescribed HRT in England increased by 6.4% in 2024/25 compared with the previous financial year, with oestrogel as the dominant individual product by prescribing volume,…
buff.ly
October 27, 2025 at 2:02 PM
The number of patients prescribed HRT in England increased by 6% in 2024/25 compared with the previous financial year, according to NHSBSA statistics.
Find out more on MIMS Pharma
Find out more on MIMS Pharma
This week's news in brief
▶️ Steroid asthma inhaler to be discontinued
▶️ Daktarin oral gel returns after 2-year absence
▶️ Amiodarone supply disrupted
Read more on MIMS
buff.ly/yge7K7d
▶️ Steroid asthma inhaler to be discontinued
▶️ Daktarin oral gel returns after 2-year absence
▶️ Amiodarone supply disrupted
Read more on MIMS
buff.ly/yge7K7d
October 24, 2025 at 2:04 PM
This week's news in brief
▶️ Steroid asthma inhaler to be discontinued
▶️ Daktarin oral gel returns after 2-year absence
▶️ Amiodarone supply disrupted
Read more on MIMS
buff.ly/yge7K7d
▶️ Steroid asthma inhaler to be discontinued
▶️ Daktarin oral gel returns after 2-year absence
▶️ Amiodarone supply disrupted
Read more on MIMS
buff.ly/yge7K7d
Local drug formulary teams and operations are to be standardised from next year, as part of moves to develop a single national formulary
Local drug formulary operations to be standardised from next year
Local drug formulary teams and operations are to be standardised from next year, as part of moves to develop a single national formulary.
buff.ly
October 24, 2025 at 10:01 AM
Local drug formulary teams and operations are to be standardised from next year, as part of moves to develop a single national formulary
Questions about menopause symptoms are to be added to routine NHS health checks, the government has announced buff.ly/VAk5boy
Women to be asked about menopause symptoms in NHS health checks
Questions about menopause symptoms are to be added to routine NHS health checks, the government has announced.
www.mims.co.uk
October 23, 2025 at 3:28 PM
Questions about menopause symptoms are to be added to routine NHS health checks, the government has announced buff.ly/VAk5boy
Antidepressants differ significantly in their effects on body mass and other cardiometabolic measures, a review has found.
Read more on MIMS:
Read more on MIMS:
Antidepressants differ significantly in their effects on body weight, research suggests
Antidepressants differ significantly in their effects on body mass and other cardiometabolic measures, a review has found.
buff.ly
October 23, 2025 at 1:31 PM
Antidepressants differ significantly in their effects on body mass and other cardiometabolic measures, a review has found.
Read more on MIMS:
Read more on MIMS:
This week's new #drugshortages include:
▶️ Amiodarone 100mg and 200mg tablets
▶️ Dalivit multivitamin drops
▶️ Valios 10mg orodispersible tablets (memantine)
For more information, see the MIMS Drugs Shortages Tracker buff.ly/tEXt6kH
▶️ Amiodarone 100mg and 200mg tablets
▶️ Dalivit multivitamin drops
▶️ Valios 10mg orodispersible tablets (memantine)
For more information, see the MIMS Drugs Shortages Tracker buff.ly/tEXt6kH
October 22, 2025 at 2:06 PM
This week's new #drugshortages include:
▶️ Amiodarone 100mg and 200mg tablets
▶️ Dalivit multivitamin drops
▶️ Valios 10mg orodispersible tablets (memantine)
For more information, see the MIMS Drugs Shortages Tracker buff.ly/tEXt6kH
▶️ Amiodarone 100mg and 200mg tablets
▶️ Dalivit multivitamin drops
▶️ Valios 10mg orodispersible tablets (memantine)
For more information, see the MIMS Drugs Shortages Tracker buff.ly/tEXt6kH
GPs are facing a significant increase in consultations with patients requesting access to weight loss drugs when they are ineligible under current NHS guidelines
Weight loss jabs trigger surge in GP workload
GPs are facing a significant increase in consultations with patients requesting access to weight loss drugs when they are ineligible under current NHS guidelines.
buff.ly
October 22, 2025 at 8:24 AM
GPs are facing a significant increase in consultations with patients requesting access to weight loss drugs when they are ineligible under current NHS guidelines
GLP-1 medications are associated with an increased risk of depression compared with SGLT2 inhibitors, according to a cohort study.
Read more on MIMS
Read more on MIMS
Prescribers should be aware of potential risk of depression with GLP-1 drugs, researchers say
GLP-1 medications are associated with an increased risk of depression compared with SGLT2 inhibitors, according to a cohort study.
buff.ly
October 18, 2025 at 1:02 PM
GLP-1 medications are associated with an increased risk of depression compared with SGLT2 inhibitors, according to a cohort study.
Read more on MIMS
Read more on MIMS
This week's news in brief
▶️ Dalivit oral drops out of stock
▶️ GLP-1 agonist discontinued
▶️ Renal outcomes data added to Ozempic SPC
Read more on MIMS
buff.ly/yge7K7d
▶️ Dalivit oral drops out of stock
▶️ GLP-1 agonist discontinued
▶️ Renal outcomes data added to Ozempic SPC
Read more on MIMS
buff.ly/yge7K7d
October 17, 2025 at 4:01 PM
This week's news in brief
▶️ Dalivit oral drops out of stock
▶️ GLP-1 agonist discontinued
▶️ Renal outcomes data added to Ozempic SPC
Read more on MIMS
buff.ly/yge7K7d
▶️ Dalivit oral drops out of stock
▶️ GLP-1 agonist discontinued
▶️ Renal outcomes data added to Ozempic SPC
Read more on MIMS
buff.ly/yge7K7d